elizabeth loder, md, professor of neurology, harvard medical school; chief, division of headache, brigham & women's hospital.
.
china's plans to import indian drugs fail to enthuse indian pharmaceutical firms
.: "fremanezumab for the preventive treatment of chronic migraine."
.
.
.
.
.
the school in yarmouth that year had a low opt-out rate � 2 percent, the superintendent said � so there was a cap on the amount of disruption an illness could cause.
.